ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer (APP22)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00583024
Recruitment Status : Active, not recruiting
First Posted : December 31, 2007
Last Update Posted : January 8, 2018
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
David M Lubaroff, University of Iowa